The preterm lung and airway: Past, present, and future

22Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Abstract

The tremendous advancement that has occurred in neonatal intensive care over the last 40-50 years can be largely attributed to greater understanding of developmental pathobiology in the newborn lung. Nonetheless, this improved survival from respiratory distress syndrome has been associated with continuing longer-term morbidity in the form of bronchopulmonary dysplasia (BPD). As a result, neonatal lung injury is a renewed focus of scientific interest. The onset of such an injury may begin in the delivery room, and this has generated interest in minimizing oxygen therapy and aggressive ventilatory support during the transition from fetal to neonatal lung. Fortunately, antenatal steroid therapy and selective use of surfactant therapy are now widely practiced, although fine tuning of this therapy for selected populations is ongoing. Newer therapeutic approaches address many aspects of BPD, including the pro-inflammatory component that characterizes this disorder. Finally, there is a greater need to understand the epidemiology and pathogenesis of the longer-term respiratory morbidity, most notably asthma, that persists in the preterm survivors of neonatal intensive care. © 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights.

Cite

CITATION STYLE

APA

Martin, R. J., & Fanaroff, A. A. (2013, August). The preterm lung and airway: Past, present, and future. Pediatrics and Neonatology. https://doi.org/10.1016/j.pedneo.2013.03.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free